Faculty Disclosures
| Josep O. Dalmau, MD, PhD, FAAN |
Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. |
| Barney J. Stern, MD, FAAN |
Dr. Stern has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Foundation for Sarcoidosis Research. The institution of Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. Dr. Stern has received publishing royalties from a publication relating to health care. |
| Jeffrey A. Cohen, MD |
Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion. |
| Massimo Filippi, MD, FAAN |
Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. |
| Brian G. Weinshenker, MD, FAAN |
Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zenas Pharma. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care. |
| Brenda L. Banwell, MD, FAAN |
Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH. |
| Merit E. Cudkowicz, MD, MSC, FAAN |
Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ac immune. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for pontifax. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inflectis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ab science. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for aclipse. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. The institution of Dr. Cudkowicz has received research support from PharmAust. The institution of Dr. Cudkowicz has received research support from woolsley. Dr. Cudkowicz has received research support from lilly. The institution of Dr. Cudkowicz has received research support from J& J. Dr. Cudkowicz has received publishing royalties from a publication relating to health care. |
| Irene Richard, MD, FAAN |
Dr. Richard has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Katten Muchin Rosenman Law Firm. The institution of Dr. Richard has received research support from Michael J Fox Foundation for Parkinson's Research. |
| Orhun H. Kantarci, MD |
Dr. Kantarci has nothing to disclose. |
| Karin Woodman, MD |
Dr. Woodman has nothing to disclose. |
| Maria A. Rocca |
Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. |
| Michael D. Geschwind, MD, PhD, FAAN |
Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc.. |
| Ilya Kister, MD, FAAN |
Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care. |
| Daniel Kantor, MD, FAAN |
Dr. Kantor has received personal compensation for serving as an employee of Gateway Institute for Brain Research. Dr. Kantor has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kantor has a non-compensated relationship as a HAP with MSFous (MSF) that is relevant to AAN interests or activities. Dr. Kantor has a non-compensated relationship as a Medical Board with MS Views & News that is relevant to AAN interests or activities. |
| Andrew McKeon, MD |
The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| Sean J. Pittock, MD, FAAN |
Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Kevin Tan, MD, FAAN |
Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. |
| Farrah J. Mateen, MD, PhD, FAAN |
Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |
| Aksel Siva, MD |
Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants. |
| Mustapha A. Ezzeddine, MD, FAAN |
The institution of Dr. Ezzeddine has received research support from NIH. |
| Robert G. Smith, MD, PhD, FAAN |
Dr. Smith has nothing to disclose. |
| Edgardo Cristiano, MD |
Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. |
| Jagarlapudi M. Murthy, MD, FAAN |
Dr. Murthy has nothing to disclose. |
| Jayawant N. Mandrekar, PhD |
Dr. Mandrekar has nothing to disclose. |
| Carlos A. Pardo-Villamizar, MD |
The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research . |
| Jerome Honnorat, MD, PhD |
Jerome Honnorat, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB. The institution of Jerome Honnorat, MD, PhD has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for journal of neurology. |
| Askiel Bruno, MD, FAAN |
The institution of Dr. Bruno has received research support from Georgia Rehabilitation Institute. The institution of Dr. Bruno has received research support from Janssen Pharma. |
| Liliana B. Patrucco, MD |
Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. |
| Eli Diamond, MD |
Dr. Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Biopharmaceuticals. Dr. Diamond has received research support from Applebaum Foundation. Dr. Diamond has received research support from Frame Family Fund. Dr. Diamond has received research support from Joy Family West Foundation. |
| Mark Keegan, MD, FAAN |
Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care. |
| Antonio Arauz, MD, PhD |
Dr. Arauz has nothing to disclose. |
| Salvador Cruz-Flores, MD, FAAN |
The institution of Dr. Cruz-Flores has received research support from University of Texas System. |
| Michael Levy, MD, PhD, FAAN |
Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health. |
| Jaime Toro, MD, FAAN |
Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology . |
| Suparna R. Krishnaiengar, MD |
Dr. Krishnaiengar has nothing to disclose. |
| Maarten J. Titulaer, MD, PhD |
The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received intellectual property interests from a discovery or technology relating to health care. Dr. Titulaer has received publishing royalties from a publication relating to health care. |
| Grace Gombolay, MD, FAAN |
The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH. Dr. Gombolay has a non-compensated relationship as a Board of Trustee with National MS Society -Georgia chapter that is relevant to AAN interests or activities. |
| Friedemann Paul |
Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation. |
| Ashok Verma, MD, FAAN |
Dr. Verma has nothing to disclose. |
| Flavia Nelson, MD |
Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brystol Meyer Squib. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genetech. The institution of Dr. Nelson has received research support from NIH. Dr. Nelson has received research support from Novartis. |
| Paisith Piriyawat, MD |
Dr. Piriyawat has nothing to disclose. |
| Daniel Pastula, MD, MHS, FAAN |
Dr. Pastula has nothing to disclose. |
| Rebecca L. Gillani, MD |
The institution of Dr. Gillani has received research support from The Phyllis and Jerome Lyle Rappaport Foundation. The institution of Dr. Gillani has received research support from McCourt Foundation . The institution of Dr. Gillani has received research support from Roche. |
| W. O. Tobin, PhD, MBBCh, BAO, FAAN |
The institution of Dr. Tobin has received research support from Merck. The institution of Dr. Tobin has received research support from National Institutes of Health. Dr. Tobin has received publishing royalties from a publication relating to health care. Dr. Tobin has received personal compensation in the range of $0-$499 for serving as a Paid consulting and advisory activities with Mayo Clinic Platform_Accelerate. |
| Jodie Burton, MD, FAAN |
Dr. Burton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Burton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Burton has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. The institution of Dr. Burton has received research support from Roy and Joan Allen Professorship for Sight. Dr. Burton has a non-compensated relationship as a Advisor with CADTH that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Alexion that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Horizon that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a 好色先生al Chair with EMD Serono that is relevant to AAN interests or activities. |
| Christopher Coffey, PhD, FAAN |
Dr. Coffey has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Coffey has received research support from NIH. The institution of Dr. Coffey has received research support from Michael J Fox Foundation. |
| Juan Ignacio Rojas, MD |
Dr. Rojas has nothing to disclose. |
| Carolin Dohle, MD |
Dr. Dohle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion TPharmaceuticals. Dr. Dohle has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. |
| Sarosh R. Irani, MD, PhD, FRCP, FEAN |
Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Argenex, Atheneum, AZ, Clarivate, IQVIA, BioHaven therapeutics. Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion US, Amgen, Argenx . Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. The institution of Dr. Irani has received research support from Amgen. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |
| Karl Krecke |
Karl Krecke has nothing to disclose. |
| Jennifer McCombe, MD |
Dr. McCombe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. |
| Patrick Waters, PhD |
Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. The institution of Dr. Waters has received research support from Guthy-Jackson Charitable Foundation. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care. |
| Samir Belagaje, MD, FAAN |
Dr. Belagaje has nothing to disclose. |
| Gregory S. Day, MD, MSc, FAAN |
Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a 好色先生al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities. |
| Jeffrey M. Gelfand, MD, MS, FAAN |
Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities. |
| Lahiru Handunnetthi, MBBS |
The institution of Dr. Handunnetthi has received research support from Janssen Pharmaceuticals. |
| Stephanie Syc-Mazurek, MD, PhD |
Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities. |
| Arun Venkatesan, MD, PhD |
Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from U.S. DOD. |
| Josmarlin Baez |
No disclosure on file
|
| Roy E. Strowd III, MD, FAAN |
Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care. |
| Katayoun Alikhani, MD |
Dr. Alikhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apotex, Biogen, Bristol Myers Squibb, EMD Serono, Novartis, Roche, Sanofi Genzyme. |
| Stacey Clardy, MD, PhD, FAAN |
Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed. |
| Su-Yin Lim, MBBS |
No disclosure on file
|
| John N. Soltys, MD |
Dr. Soltys has nothing to disclose. |
| Jan-Mendelt Tillema, MD |
Dr. Tillema has nothing to disclose. |
| Michael R. Wilson, MD, FAAN |
Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ouro Medicines. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Indapta Therapeutics. Dr. Wilson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cambridge Medical Experts. Dr. Wilson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dunham Hallmark. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. The institution of Dr. Wilson has received research support from Chan Zuckerberg Initiative. The institution of Dr. Wilson has received research support from Kyverna Therapeutics. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice. |
| Yedatore S. Venkatesh, MD, FAAN |
Dr. Venkatesh has nothing to disclose. |
| Peter Sillevis Smitt, MD |
The institution of Dr. Sillevis Smitt has received research support from Euroimmun. Dr. Sillevis Smitt has received intellectual property interests from a discovery or technology relating to health care. |
| Enrique Alvarez, MD, PhD |
Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. |
| Vikram Bhise, MD |
Dr. Bhise has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharmaceuticals. The institution of Dr. Bhise has received research support from Horizon Blue Cross Blue Shield. |
| Erik V. Burton, MD |
Dr. Burton has nothing to disclose. |
| Eoin P. Flanagan, MBBCh, FAAN |
The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities. |
| Shruti P. Agnihotri, MD |
An immediate family member of Dr. Agnihotri has stock in Pfizer. The institution of Dr. Agnihotri has received research support from Roche/ Genentech. |
| John Probasco, MD, FAAN |
Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech. |
| Samir Alkabie, MD, MSc |
Dr. Alkabie has nothing to disclose. |
| Irena Dujmovic Basuroski, MD, PhD |
The institution of Dr. Dujmovic Basuroski has received research support from Alexion Pharmaceuticals, Inc. The institution of Dr. Dujmovic Basuroski has received research support from Biogen MA Inc. The institution of Dr. Dujmovic Basuroski has received research support from EMD Serono Research and Development Institute, Inc . The institution of Dr. Dujmovic Basuroski has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Dujmovic Basuroski has received research support from The Bodford Family Transverse Myelitis Center Fund. The institution of Dr. Dujmovic Basuroski has received research support from CorEvitas, LLC. The institution of Dr. Dujmovic Basuroski has received research support from Novartis. The institution of Dr. Dujmovic Basuroski has received research support from Ad Scientiam. Dr. Dujmovic Basuroski has received personal compensation in the range of $0-$499 for serving as a Travel -related expenses to attend clinical trial investigator meeting with Novartis. Dr. Dujmovic Basuroski has received personal compensation in the range of $500-$4,999 for serving as a International Clinical Consortium Member, Travel -related expenses to attend the meeting with The Guthy-Jackson Charitable Foundation. |
| Rola Mahmoud, MD |
Dr. Mahmoud has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics, EMD Serono, Amgen and Sanofi . Dr. Mahmoud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD sorono. |
| Cristina Valencia Sanchez, MD |
Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Valencia Sanchez has a non-compensated relationship as a member of the medical advisory board with The MOG Project that is relevant to AAN interests or activities. |
| Saher Choudhary, MD |
Dr. Choudhary has nothing to disclose. |
| Michel Toledano, MD |
Dr. Toledano has nothing to disclose. |
| Sudarshini Ramanathan, MBBS, PhD, FRACP |
Dr. Ramanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Ramanathan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Alexion, Novartis. The institution of Dr. Ramanathan has received research support from NHMRC, RACP, University of Sydney. |
| Daniel Anthony, PhD, MA |
Dr. Anthony has received personal compensation for serving as an employee of University of Oxford. Dr. Anthony has received personal compensation for serving as an employee of Somerville College Oxford. Dr. Anthony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Anthony has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroplast. Dr. Anthony has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Oxomics. The institution of Dr. Anthony has received research support from Numares. The institution of Dr. Anthony has received research support from MRC UK. |
| Lei Liu, MD, PhD |
Dr. Liu has nothing to disclose. |
| Hyun J. Cho, MD |
Dr. Cho has nothing to disclose. |
| Saif Huda, MD |
Dr. Huda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. |
| Raffaele Iorio, MD |
Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Therapeutics. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson. |
| Lawrence M. Samkoff, MD, FAAN |
Dr. Samkoff has nothing to disclose. |
| David R. Benavides, MD, PhD, FAAN |
The institution of Dr. Benavides has received research support from NIH/NINDS. The institution of Dr. Benavides has received research support from F. Hoffman La Roche Ltd. |
| Ning Zhong, MD |
Dr. Zhong has nothing to disclose. |
| Simon Broadley, PhD, FRACP |
The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Broadley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. The institution of Dr. Broadley has received research support from NHMRC. The institution of Dr. Broadley has received research support from ARC. The institution of Dr. Broadley has received research support from GCH Foundation. The institution of Dr. Broadley has received research support from NHMRC. |
| Ugur Uygunoglu |
Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey. |
| Rajesh K. Gupta, MBBS |
Dr. Gupta has nothing to disclose. |
| Stephen L. Yates, PhD |
Dr. Yates has received personal compensation for serving as an employee of UCB Biosciences, Inc.. Dr. Yates has stock in UCB Biosciences, Inc.. |
| Yael Shiloh-Malawsky, MD |
Dr. Shiloh-Malawsky has nothing to disclose. |
| Adam Handel |
No disclosure on file
|
| Hesham A. Abboud, MD |
Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care. |
| Divyanshu Dubey, MD, FAAN |
The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |
| Scott M. Belliston, DO |
Dr. Belliston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Shamik Bhattacharyya, MD, FAAN |
Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. |
| Manan Shah, MD, MBBS |
Dr. Shah has nothing to disclose. |
| Gail J. Ocana, MD, PhD |
Dr. Ocana has nothing to disclose. |
| Alexander J. Gill, MD, PhD |
Dr. Gill has received personal compensation for serving as an employee of Novartis Pharmaceuticals Corporation. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medical Logix, LLC. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Health Union, LLC . Dr. Gill has received research support from National Multiple Sclerosis Society. Dr. Gill has a non-compensated relationship as a President, Treasurer, and Member of Board of Directors with Autoimmune Neurology Research Consortium, Inc. that is relevant to AAN interests or activities. |
| Sage T. Hewitt, MD |
Dr. Hewitt has nothing to disclose. |
| Veronica Rivas |
Veronica Rivas has nothing to disclose. |
| Amanda L. Piquet, MD, FAAN |
The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities. |
| Jafar Kafaie, MD, PhD, FAAN |
Dr. Kafaie has nothing to disclose. |
| Jenny Linnoila, MD, PhD |
Dr. Linnoila has received personal compensation in the range of $10,000-$49,999 for serving as a expert respondent on autoimmune encephalitis with U.S. government/DHHS/Vaccine Injury Compensation Program. |
| Suad Y. Khalil, MD |
Dr. Khalil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ucb. |
| Alfonso S. Lopez, MD |
Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . |
| Giovanna Manzano, MD |
Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx. |
| Sushma R. Yerram, MD |
Dr. Yerram has nothing to disclose. |
| Shailee S. Shah, MD |
Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care. |
| Alexander Carvajal- Gonzalez, MD, PhD |
Dr. Carvajal- Gonzalez has nothing to disclose. |
| Monique Anderson, MD, PhD |
Dr. Anderson has nothing to disclose. |
| Laura Cacciaguerra, MD, PhD |
Dr. Cacciaguerra has nothing to disclose. |
| Eyal Muscal |
Eyal Muscal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sobi. An immediate family member of Eyal Muscal has stock in pfizer. |
| Rodrigo Hasbun |
Rodrigo Hasbun has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biomeriaux. The institution of Rodrigo Hasbun has received research support from Biomeriaux. |
| Saul Reyes, MD |
Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. |
| Joseph DeRisi, PhD |
Joseph DeRisi, PhD has received personal compensation for serving as an employee of Chan Zuckerberg Biohub. Joseph DeRisi, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allen & Co. Joseph DeRisi, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Public Health Company, Inc. Joseph DeRisi, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for Delve Bio. Joseph DeRisi, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for VeriPhi Inc. The institution of Joseph DeRisi, PhD has received research support from Chan Zuckerberg Biohub. Joseph DeRisi, PhD has received intellectual property interests from a discovery or technology relating to health care. |
| Chantal Roy-Hewitson, MD |
Dr. Roy-Hewitson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Dr. Roy-Hewitson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. |
| William A. Kilgo, MD, FAAN |
Dr. Kilgo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kilgo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Kilgo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Kilgo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. |
| Marisa P. McGinley, DO |
Dr. McGinley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH. The institution of Dr. McGinley has received research support from AHRQ. The institution of Dr. McGinley has received research support from EMD Serono. |
| Nidhi Kapoor, MD, MBBS, FAAN |
Dr. Kapoor has nothing to disclose. |
| Nidhiben A. Anadani, MD |
Dr. Anadani has nothing to disclose. |
| Dmitriy Labunskiy |
Mr. Labunskiy has nothing to disclose. |
| Ka-Ho Wong |
The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association. |
| Lionel D. Vazquez-Figueroa, MD |
Dr. Vazquez-Figueroa has nothing to disclose. |
| Carol Swetlik, MD |
An immediate family member of Dr. Swetlik has received personal compensation for serving as an employee of Pfizer. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. |
| Carsten Finke, MD |
Carsten Finke, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myer Squibb. The institution of Carsten Finke, MD has received research support from Euroimmun. |
| Hongfei Gu |
Hongfei Gu has nothing to disclose. |
| Andreas Lutterotti |
No disclosure on file
|
| Rajiv Anand, MD |
Dr. Anand has nothing to disclose. |
| Dilip Singh, MD, MBBS |
Dr. Singh has nothing to disclose. |
| Atul Prasad, MD |
Dr. Prasad has nothing to disclose. |
| Leah L. Wibecan, MD, MPH |
Dr. Wibecan has nothing to disclose. |
| Saman Zafar, MD |
Dr. Zafar has nothing to disclose. |
| Yong Guo |
Yong Guo has nothing to disclose. |
| John Chen |
John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. |
| Abhilash Thatikala, MD, MBBS, DM |
Dr. Thatikala has nothing to disclose. |
| Carlos Isada |
No disclosure on file
|
| Kristin M. Galetta, MD |
Dr. Galetta has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS. |
| Burcu Zeydan, MD |
The institution of Dr. Zeydan has received research support from National Institutes of Health. |
| Ivan D. Carabenciov, MD |
Dr. Carabenciov has nothing to disclose. |
| Lekha Pandit |
Lekha Pandit has nothing to disclose. |
| Elia Sechi, MD |
Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. |
| Brittany Lapin |
No disclosure on file
|
| Anastasia Zekeridou, MD, PhD, FAAN |
The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. |
| Yesenia Enriquez-Gonzalez, MD |
Dr. Enriquez-Gonzalez has nothing to disclose. |
| Mateusz Makuch |
No disclosure on file
|
| Andrew Murchison |
No disclosure on file
|
| Nikita Shukla, MD |
The institution of Dr. Shukla has received research support from Roche. |
| Mark Waheed, DO |
Dr. Waheed has nothing to disclose. |
| Jose J. Flores-Rivera, MD |
Dr. Flores-Rivera has nothing to disclose. |
| Avi Gadoth, MD |
Dr. Gadoth has received intellectual property interests from a discovery or technology relating to health care. |
| Shemonti Hasan, MD |
Dr. Hasan has nothing to disclose. |
| Sankeerth Challagundla, MD |
Dr. Challagundla has nothing to disclose. |
| Kevin C. O'Connor, PhD |
Kevin C. O'Connor, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Immunovant. Kevin C. O'Connor, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Kevin C. O'Connor, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurocrine. Kevin C. O'Connor, PhD has stock in Cabaletta. The institution of Kevin C. O'Connor, PhD has received research support from Seismic. The institution of Kevin C. O'Connor, PhD has received research support from Argenx. Kevin C. O'Connor, PhD has received intellectual property interests from a discovery or technology relating to health care. |
| Samhita Panda, MD, DM |
Dr. Panda has nothing to disclose. |
| Kristen Fisher, DO |
Dr. Fisher has nothing to disclose. |
| Anthony J. Brune III, DO |
Dr. Brune has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Pharmaceuticals. |
| Amy Kunchok, MBBS |
Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal . |
| Tanu Garg, MD |
Dr. Garg has nothing to disclose. |
| Philippe-Antoine Bilodeau, MD |
Dr. Bilodeau has or had stock in Roche. The institution of Dr. Bilodeau has received research support from Alexion Pharmaceuticals. The institution of Dr. Bilodeau has received research support from Department of Defense. Dr. Bilodeau has received research support from Canadian Institutes of Health Research. The institution of Dr. Bilodeau has received research support from Ann Theodore Foundation. Dr. Bilodeau has received research support from The MOG Project. |
| Tammy L. Smith, MD, PhD |
Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca. |
| Kasser Saba, MD |
Dr. Saba has nothing to disclose. |
| Arvin Parvathaneni, MD |
Dr. Parvathaneni has nothing to disclose. |
| Neal Sankhla, MD |
Dr. Sankhla has nothing to disclose. |
| Ahmad Mahadeen, MD |
Dr. Mahadeen has nothing to disclose. |
| Lincoln Darla, MD |
Dr. Darla has nothing to disclose. |
| Melih Tutuncu, MD |
Dr. Tutuncu has nothing to disclose. |
| Enrique Gomez Figueroa, MD, MSc |
Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson LATAM. |
| Gabriela A. Bou, MD |
Dr. Bou has nothing to disclose. |
| Anna Bastiaansen |
Anna Bastiaansen has nothing to disclose. |
| Bade Gulec |
Bade Gulec has nothing to disclose. |
| Svetlana Kiryukhina |
No disclosure on file
|
| Mark J. Kelly, MBBS |
The institution of Dr. Kelly has received research support from The Health Research Board / Wellcome Trust. |
| Rohan Sharma, MD |
Dr. Sharma has nothing to disclose. |
| Ragha Sakuru, MD |
Dr. Sakuru has nothing to disclose. |
| Jesús Ramírez-Bermúdez |
No disclosure on file
|
| Ludivine Chamard Witkowski |
Ludivine Chamard Witkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ludivine Chamard Witkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck Serono. The institution of Ludivine Chamard Witkowski has received research support from CFMNB. The institution of Ludivine Chamard Witkowski has received research support from Cantrain. |
| Marienke de Brujin |
Marienke de Brujin has nothing to disclose. |
| Rumyar V. Ardakani, MD |
Dr. Ardakani has nothing to disclose. |
| Samuel Pleasure, MD, PhD |
Dr. Pleasure has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Pleasure has received research support from NINDS, NIMH, NIDA, National MS Society, Brain Research Foundation, John Merck Fund, Whitehall Foundation, Lupus Research Association, Juvenile Diabetes Research Foundation. |
| Anastasia Vishnevetsky, MD |
The institution of Dr. Vishnevetsky has received research support from National MS Society. The institution of Dr. Vishnevetsky has received research support from NIH (NeuroNext). |
| Greer Waldrop, MD |
Dr. Waldrop has nothing to disclose. |
| Soon-Tae Lee, MD, PhD |
Prof. Lee has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Piehealthcare. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salted. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Prof. Lee has received research support from Roche. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care. |
| Elizabeth Matthews, MD |
Dr. Matthews has nothing to disclose. |
| Yair Mina, MD |
Dr. Mina has nothing to disclose. |
| Chaitanya Medicherla, MD |
Dr. Medicherla has nothing to disclose. |
| Deena Tajfirouz, MD |
Dr. Tajfirouz has nothing to disclose. |
| Benjamin T. Alwood, MD |
Dr. Alwood has nothing to disclose. |
| Ofer Rotschild |
Ofer Rotschild has nothing to disclose. |
| Samantha Anne Gutierrez, MD |
Dr. Gutierrez has nothing to disclose. |
| Sarbesh Tiwari |
Sarbesh Tiwari has nothing to disclose. |
| Alexander Sandweiss, MD, PhD |
Dr. Sandweiss has nothing to disclose. |
| Sarah Conway, MD |
Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Live. |
| Denis Baranov |
No disclosure on file
|
| Celeste R. Camargo, MD |
Dr. Camargo has nothing to disclose. |
| H. Benjamin Larman |
H. Benjamin Larman has received personal compensation for serving as an employee of Infinity Bio. H. Benjamin Larman has or had stock in Infinity Bio.H. Benjamin Larman has received intellectual property interests from a discovery or technology relating to health care. |
| Varun Suroliya |
No disclosure on file
|
| Will K. Tanigaki, MD |
Mr. Tanigaki has nothing to disclose. |
| Carson M. Quinn, MD |
Dr. Quinn has nothing to disclose. |
| Mariana Espinola-Nadurille |
No disclosure on file
|
| Shanthi Viswanathan |
No disclosure on file
|
| Yarden Bornovski, MD |
Dr. Bornovski has nothing to disclose. |
| Meryim Poursheykhi, MD |
Dr. Poursheykhi has nothing to disclose. |
| Barrie L. Zerwic, MD |
Dr. Schmitt has nothing to disclose. |
| Caleigh Mandel-Brehm, PhD |
The institution of Dr. Mandel-Brehm has received research support from NIH-NINDS K99/R00 grant. Dr. Mandel-Brehm has received intellectual property interests from a discovery or technology relating to health care. |
| Takahisa Mikami, MD |
Dr. Mikami has nothing to disclose. |
| Ramsha A. Bhutta, MD |
Dr. Bhutta has nothing to disclose. |
| Claudia M. Prospero Ponce, MD |
Dr. Prospero Ponce has nothing to disclose. |
| Nisa Vorasoot, MD |
Dr. Vorasoot has nothing to disclose. |
| Hafsa Bareen Syeda, MBBS |
Dr. Syeda has nothing to disclose. |
| Suzanne Crandall, DO |
Dr. Crandall has nothing to disclose. |
| Rosemarie E. Walch, DO |
Dr. Walch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Walch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Walch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Walch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Walch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Walch has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walch has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Walch has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Walch has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Walch has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Walch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Walch has received research support from Genentech/Roche. The institution of Dr. Walch has received research support from Sanofi. The institution of Dr. Walch has received research support from EMD Serono. Dr. Walch has received research support from TG Therapeutics . The institution of Dr. Walch has received research support from Novartis. The institution of Dr. Walch has received research support from Alexion. The institution of Dr. Walch has received research support from Amgen . |
| Melissa A. Wright, MD |
Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . |
| Nicholas J. Reish, MD, PhD |
Dr. Reish has nothing to disclose. |
| Nathan McGraw, MD |
Dr. McGraw has nothing to disclose. |
| Stefanie J. Rodenbeck, MD |
Dr. Rodenbeck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. |
| Ahya S. Ali, MD |
Dr. Ali has nothing to disclose. |
| Paul D. Crane, MD |
Dr. Crane has nothing to disclose. |
| Megan A. Hansen, MD |
Dr. Hansen has nothing to disclose. |
| Emily Trenholm |
No disclosure on file
|
| Ajay Madhavan |
Ajay Madhavan has nothing to disclose. |
| Yifat Alcalay |
Yifat Alcalay has nothing to disclose. |
| Orna Aizenstein Lehavi |
Orna Aizenstein Lehavi has nothing to disclose. |
| Anza Zahid, MD, MBBS |
Dr. Zahid has nothing to disclose. |
| Robyn Howarth |
No disclosure on file
|
| Yael Paran |
Yael Paran has nothing to disclose. |
| Darshan A. Dave, MD |
Dr. Dave has nothing to disclose. |
| Ava M. Easton, PhD |
Dr. Easton has received personal compensation for serving as an employee of Encephalitis Society. Dr. Easton has received publishing royalties from a publication relating to health care. |
| Spencer Hutto, MD |
Dr. Hutto has nothing to disclose. |
| Jon A. Karel, MD |
Dr. Karel has nothing to disclose. |
| Sonam Mohan, MD, PhD |
Dr. Mohan has nothing to disclose. |
| Albert Aboseif, DO |
Dr. Aboseif has received research support from the Eugene & Marcia Applebaum Fellowship Grant. |
| Shaily Patel, MD |
Dr. Patel has nothing to disclose. |
| Sanem P. Uysal, MD |
Dr. Uysal has nothing to disclose. |
| Zachary T. Lazzari, MD |
Dr. Lazzari has nothing to disclose. |
| Juan Solano, MD |
Dr. Solano has nothing to disclose. |
| Miguel F. Cabanillas Lazo |
Mr. Cabanillas Lazo has nothing to disclose. |
| Ashley Streseman, MD |
Dr. Streseman has nothing to disclose. |
| Shubham Biyani, MBBS |
Dr. Biyani has nothing to disclose. |
| Manali Desai, DO |
Dr. Desai has nothing to disclose. |
| Emma J. Orozco, MD |
Dr. Orozco has nothing to disclose. |
| Jairo A. Gaitan Alfonso, MD |
Dr. Gaitan Alfonso has nothing to disclose. |
| Allyson Heng, MD |
Dr. Heng has nothing to disclose. |
| Yoji Hoshina, MD |
Dr. Hoshina has nothing to disclose. |
| Prabandh R. Buchhanolla, MBBS |
Dr. Buchhanolla has nothing to disclose. |
| Rebecca Salky |
Rebecca Salky has nothing to disclose. |
| Vyanka Redenbaugh, MB BCh BAO |
Dr. Redenbaugh has nothing to disclose. |
| Jingxiao Zhang |
Dr. Zhang has nothing to disclose. |
| Susana Dominguez Penuela, MD |
Dr. Dominguez Penuela has nothing to disclose. |
| Khushboo Verma, MBBS |
Dr. Verma has nothing to disclose. |
| Hira Zafar, MBBS |
Dr. Zafar has nothing to disclose. |
| Yerasu Muralidhar Reddy, MD |
Dr. Muralidhar Reddy has nothing to disclose. |
| Varun Kannan, MD |
Dr. Kannan has nothing to disclose. |
| Sophie Binks, MD, MBBS, PhD |
The institution of Dr. Binks has received research support from Wellcome Trust. The institution of Dr. Binks has received research support from PetSavers. The institution of Dr. Binks has received research support from PetPlan. The institution of Dr. Binks has received research support from NIHR. The institution of Dr. Binks has received research support from Morris Animal Foundation. Dr. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ECTRIMS. Dr. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with Vetmeduni Wien. Dr. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ANA. Dr. Binks has a non-compensated relationship as a Speaker with Encephalitis Society UK that is relevant to AAN interests or activities. Dr. Binks has a non-compensated relationship as a Scientific Panel Member with Encephalitis International that is relevant to AAN interests or activities. Dr. Binks has a non-compensated relationship as a Editorial Fellow with JAMA Neurology that is relevant to AAN interests or activities. |
| Yahel Segal, MD |
Dr. Segal has nothing to disclose. |
| Kristy Murray |
No disclosure on file
|
| Juliette Brenner, MD |
Ms. Brenner has nothing to disclose. |
| Jordan Carrier, MD |
Dr. CARRIER has nothing to disclose. |
| Naila Kausar, MD |
Dr. Kausar has nothing to disclose. |
| Sanjith Prahas Krishnam, MBBS |
Dr. Krishnam has nothing to disclose. |
| John Pluvinage, MD, PhD |
The institution of Dr. Pluvinage has received research support from NINDS. |
| Jesse Levine, MD, PhD |
Dr. Levine has nothing to disclose. |
| Tianrong Yeo, MBBS |
The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving as a Consultant for Edanz Pharma. The institution of Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Terumo BCT. The institution of Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Euroimmun AG . The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis . The institution of Dr. Yeo has received research support from National Medical Research Council (Singapore) . The institution of Dr. Yeo has received research support from Roche . |
| Christopher E. Uy, MD |
Dr. Uy has received personal compensation in the range of $500-$4,999 for serving as a IVIG for CNS Disease Task Force Member with Provincial Blood Coordinating Office (British Columbia). |
| Cheng Chin Wang, DO |
Dr. Wang has nothing to disclose. |
| Axel M. Baez-Lugo, MD |
Dr. Baez-Lugo has nothing to disclose. |
| Mattia Wruble, MD |
The institution of Dr. Wruble has received research support from Alexion. The institution of Dr. Wruble has received research support from Roche. |
| Jonathan Yarimi, MD |
Dr. Yarimi has nothing to disclose. |
| Zheming Yu, MD |
Dr. Yu has nothing to disclose. |
| Claudia Cruzalegui Bazán |
Miss Cruzalegui Bazán has nothing to disclose. |
| Wilson E. Rodriguez, MD |
Dr. Rodriguez has nothing to disclose. |
| Thirumalaivasan Dhasakeerthi, MBBS |
Dr. Dhasakeerthi has nothing to disclose. |
| Janice M. Rivera, MD |
Dr. Rivera has nothing to disclose. |
| Muhammad Ayub, MD |
Dr. Ayub has nothing to disclose. |
| Lingxuan Li |
Miss Li has nothing to disclose. |
| Octavio Arevalo |
No disclosure on file
|
| Karla Salazar, MD |
Dr. Salazar has nothing to disclose. |
| Cisse Amara |
No disclosure on file
|
| Gadi A. Maayan Eshed, MD |
Dr. Maayan Eshed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bionaut Labs Ltd. |
| Michal Dekel |
No disclosure on file
|
| Eleanor Grant |
No disclosure on file
|
| Ronit Cohen-Poradosu |
No disclosure on file
|
| Virginie Desestret |
Virginie Desestret has nothing to disclose. |
| Yvette Crijnen |
Yvette Crijnen has nothing to disclose. |
| Juna De Vries |
Juna De Vries has nothing to disclose. |
| Carlos Rodrigo Q. Vicuña |
Mr. Vicuña has nothing to disclose. |
| Bonny Alvarenga |
No disclosure on file
|
| Carolina Burgos-Aguilar |
No disclosure on file
|
| Gabriela Romanow |
Gabriela Romanow has nothing to disclose. |
| Tal Levinson |
No disclosure on file
|
| Fintan Sheerin |
No disclosure on file
|
| Alessandro Dinoto, MD |
The institution of Dr. Dinoto has received research support from Encephalitis International . The institution of Dr. Dinoto has received research support from Autoimmune Encephalitis Alliance. |
| Adi Ashkenazi |
No disclosure on file
|
| Ashley Vincenty-Acosta, MD |
Miss Vincenty-Acosta has nothing to disclose. |
| Andrew Wolf, MD |
The institution of Dr. Wolf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Wolf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Wolf has received research support from Genentech. The institution of Dr. Wolf has received research support from Rocky Mountain MS Center. The institution of Dr. Wolf has received research support from Michael J. Fox Foundation. The institution of Dr. Wolf has received research support from Sanofi. The institution of Dr. Wolf has received research support from Alexion. The institution of Dr. Wolf has received research support from Novartis. The institution of Dr. Wolf has received research support from TG Therapeutics. The institution of Dr. Wolf has received research support from BMS. Dr. Wolf has received publishing royalties from a publication relating to health care. Dr. Wolf has received publishing royalties from a publication relating to health care. Dr. Wolf has received personal compensation in the range of $0-$499 for serving as a Speaker with Rocky Mountain MS Center. Dr. Wolf has a non-compensated relationship as a Board Member with Autoimmune Neurology Research Consortium that is relevant to AAN interests or activities. |
| J. D. Jordan, MD, PhD |
Dr. Jordan has nothing to disclose. |
| Natalia A. Crenesse-Cozien, MD |
Dr. Crenesse-Cozien has nothing to disclose. |
| Gerald Wallace IV, MD |
Dr. Wallace has nothing to disclose. |
| Mallory Lowe, MD |
Dr. Lowe has received research support from Kyverna Therapeutics. |
| Hannah Kopinsky, MD |
Dr. Kopinsky has nothing to disclose. |
| Angela P. Salemi, MD |
Dr. Salemi has nothing to disclose. |
| Sakhi A. Bhansali, MD |
Dr. Bhansali has nothing to disclose. |
| Serdar Akkol, MD, PhD |
Dr. Akkol has nothing to disclose. |
| Saira Afzal, MD |
Dr. Afzal has nothing to disclose. |
| Gowri Anil Peethambar, MBBS |
Dr. Anil Peethambar has nothing to disclose. |
| Andre Lapeyre Rivera |
Mr. Lapeyre Rivera has nothing to disclose. |
| Shirali Pandya, PhD |
Dr. Pandya has received personal compensation for serving as an employee of Alexion, Astra Zeneca Rare Disease. Dr. Pandya has received personal compensation for serving as an employee of Rhythm Pharmaceuticals. Dr. Pandya has stock in Sanofi. Dr. Pandya has stock in Alexion, Astra Zeneca Rare Disease. |
| Prashanth Rajarajan, MD, PhD |
Dr. Rajarajan has nothing to disclose. |
| Zainab Al Obaidi, MD |
Dr. Al Obaidi has nothing to disclose. |
| Anusha Gadipudi, MD |
Miss Gadipudi has nothing to disclose. |
| Ifrah Waris, MD |
Ms. Waris has nothing to disclose. |
| Sidarrth Prasad, MBBS |
Sidarrth Prasad has nothing to disclose. |
| Mamadou Diallo, MD |
Dr. Diallo has nothing to disclose. |
| Muhammad Ahmed Ayaz, MBBS |
Dr. Ayaz has nothing to disclose. |
| Naomi R. Kass |
Ms. Kass has nothing to disclose. |
| Divya Singh, MD |
Dr. Singh has nothing to disclose. |
| Santiago Martinez Sosa, MBBS |
Dr. Martinez Sosa has nothing to disclose. |
| Georgios Mangioris, MD |
Dr. Mangioris has nothing to disclose. |
| Bijoya Basu |
Miss Basu has nothing to disclose. |
| Muhammad Khalid, MD |
Dr. Khalid has nothing to disclose. |
| Patricio Castro Suarez |
Mr. Castro Suarez has nothing to disclose. |
| Ora Halutz |
No disclosure on file
|
| Anthony Zoghbi |
No disclosure on file
|
| Ravi Dandekar |
Ravi Dandekar has nothing to disclose. |
| Gowri Warikoo |
Ms. Warikoo has nothing to disclose. |
| Navreet T. Chennu, MD |
Mr. Chennu has nothing to disclose. |
| Ralph Habis, MD |
Dr. Habis has nothing to disclose. |
| Ana Franceschi |
Ana Franceschi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Life Molecular Imaging. Ana Franceschi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Blue Earth Diagnostics. Ana Franceschi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Ana Franceschi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Ana Franceschi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Ana Franceschi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Ana Franceschi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs.ai. Ana Franceschi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MIM Software. Ana Franceschi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Siemens Healthineers. Ana Franceschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Ana Franceschi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AJNR. The institution of Ana Franceschi has received research support from Foundation of the ASNR. Ana Franceschi has received publishing royalties from a publication relating to health care. |
| Andres Chavez-Barragan |
No disclosure on file
|
| Andrew Siyoon Ham |
Andrew Siyoon Ham has nothing to disclose. |
| Gerardo M. Luna-Peralta |
Mr. Luna-Peralta has nothing to disclose. |
| Timothy Zhang |
Timothy Zhang has nothing to disclose. |
| Gavin DeFisser |
Mr. DeFisser has nothing to disclose. |
| Joseph Murray |
No disclosure on file
|
| Lucy Kennedy |
No disclosure on file
|
| Itamar Moreno |
No disclosure on file
|
| Avi Singh Gandh, MD |
Dr. Gandh has nothing to disclose. |
| Andrew Sefain, MD |
Dr. Sefain has nothing to disclose. |
| Bruna Leles Vieira de Souza, MD |
Miss Leles Vieira de Souza has nothing to disclose. |
| Tarek F. Bakdash, MD |
Dr. Bakdash has nothing to disclose. |
|
No disclosure on file
|
| Dane Breker, MD |
Dr. Breker has nothing to disclose. |
| Joshua J. Chalkley, DO |
Dr. Chalkley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Chalkley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. |
| Christina R. Reynolds, MD |
Dr. Reynolds has nothing to disclose. |
| Jun Ho Kim, MD |
Dr. Kim has nothing to disclose. |
| Lokesh Jha, MD |
Dr. Jha has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Jha has stock in Alexion Pharmaceuticals. |
| Jose D. Villegas, MD |
Dr. Villegas has nothing to disclose. |
| Josiah Gerdts, MD, PhD |
No disclosure on file
|
| Pavel Krupenin, MD |
Dr. Krupenin has nothing to disclose. |
| Juber D. Shaikh, MD, DM (neurology) |
Dr. Shaikh has nothing to disclose. |
| Prabhumallikarjun Patil, MD |
Dr. Patil has nothing to disclose. |
| Jenny C. Reategui, MD |
Dr. Reategui has nothing to disclose. |
| Rochelle M. Kinssies, DO |
Ms. Kinssies has nothing to disclose. |
| Raquel P. Portugal, MD |
Dr. Portugal has nothing to disclose. |
| Enedina M. Lobato de Oliveira, MD, PhD |
Dr. Lobato de Oliveira has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lobato de Oliveira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. |
| Steven S. Papas, MD |
Dr. Papas has nothing to disclose. |
| Danfeng Wang, MD |
No disclosure on file
|
| Matthew McCay, MD |
Dr. McCay has nothing to disclose. |
| Nimalan Harinesan, MBBS |
Dr. Harinesan has nothing to disclose. |
| Amy Poindexter, NP |
Ms. Poindexter has nothing to disclose. |
| Salvador M. Medina, MD |
Dr. Medina has nothing to disclose. |
| Kathryn L. Boylan, MD |
Dr. Boylan has nothing to disclose. |
| Chao-Hsien Chen, MD, PhD |
Dr. Chen has nothing to disclose. |
| Alaa S. Mohamed, MD, MBBS |
Dr. Mohamed has nothing to disclose. |
| Majid M. Haditaghi, MD |
Dr. Haditaghi has nothing to disclose. |
| Ashwin Achuthaprasad, MD |
Dr. Achuthaprasad has nothing to disclose. |
| Decai Tian, Sr., PhD |
Dr. Tian has nothing to disclose. |
| Afeerah Malik, MD |
Dr. Malik has nothing to disclose. |
| Jaknel Brown, MD |
Dr. Brown has nothing to disclose. |
| Yashira M. Torres-Ramirez, MD |
Dr. Torres-Ramirez has nothing to disclose. |
| Misbah Azeem, MBBS |
Dr. Azeem has nothing to disclose. |
| Taylor M. Lakusta-Wong, MD |
Dr. Lakusta-Wong has nothing to disclose. |
| Mingyu LI, MD |
Dr. LI has nothing to disclose. |
| Vinaykumar Tallavajhala, MD |
Dr. Tallavajhala has nothing to disclose. |
| Samantha Plum, MD |
Dr. Scoville has nothing to disclose. |
| Nisha Kashyap |
Miss Kashyap has nothing to disclose. |
| Irving Fuentes |
Mr. Fuentes has nothing to disclose. |
| Jessica J. Garcia-Chan, MD |
Dr. Garcia-Chan has nothing to disclose. |
| Stella Adetokunbo, MD |
Dr. Adetokunbo has nothing to disclose. |
| Sefali Patel, DO |
Dr. Patel has nothing to disclose. |
| Alison E. Burkett, MD |
Dr. Burkett has nothing to disclose. |
| Junaid M. Essa, DO |
Dr. Essa has nothing to disclose. |
| Ahda F. Jbarah, MD |
Dr. Jbarah has nothing to disclose. |
| Laura Polhemus, MD |
Dr. Polhemus has nothing to disclose. |
| Neesha Jahani |
Miss Jahani has nothing to disclose. |
| Annalisa Dialino-Felix |
Ms. Dialino-Felix has received personal compensation for serving as an employee of Amgen. |
| Jayksh Chhabra, MBBS |
Dr. Chhabra has nothing to disclose. |
| Deyanira Ramirez, MD |
No disclosure on file
|
| Mia Unsworth |
Mrs. Unsworth has nothing to disclose. |
| Deepinder K. Maini, PhD |
Dr. Maini has nothing to disclose. |
| Amy H. Sim, MD |
Dr. Sim has nothing to disclose. |
| Madison Ott, MD |
Dr. Ott has nothing to disclose. |
| Sydney K. Smith, MD |
Dr. Smith has nothing to disclose. |
| Marina Shenouda |
Miss Shenouda has nothing to disclose. |
| Bo Sun, MBBS |
Dr. Sun has nothing to disclose. |
| Farwah N. Fatima, MD, MBBS |
Dr. Fatima has nothing to disclose. |
| Sharon A. Zachariah |
Miss Zachariah has nothing to disclose. |
| Julia Guido |
Miss Guido has nothing to disclose. |
| MIRIAN CASTAÑEDA, Jr., MD |
Miss CASTAÑEDA has nothing to disclose. |
| Megan Goyal, MD |
Miss Goyal has nothing to disclose. |
| Krishna Kanth Ravi, MD, MBBS, DNB DM |
Dr. Ravi has nothing to disclose. |
| Raul A. Comme Debroth, MD |
Dr. Comme Debroth has nothing to disclose. |
| Lynette M. Fisher |
Miss Fisher has nothing to disclose. |
| Sandra Samuel, MD |
Ms. Samuel has nothing to disclose. |
| Charlotte Mattson |
Miss Mattson has nothing to disclose. |
| Ariya Beitollahi |
Mr. Beitollahi has nothing to disclose. |
| Anna L. Harrison |
Ms. Harrison has nothing to disclose. |
| John D. Sawyer II, BS |
Mr. Sawyer has nothing to disclose. |
| Kenneth N. Le May |
Mr. Le May has nothing to disclose. |
| Borna Amir-kabirian, MD |
Dr. Amir-kabirian has nothing to disclose. |
| Elizabeth Ledbetter |
Miss Ledbetter has nothing to disclose. |
| Wan-Hsuan Chen, DO |
Dr. Chen has nothing to disclose. |
| Kelsey Hilaire, DO |
Dr. Hilaire has nothing to disclose. |
| Kimberly Imoh |
Ms. Imoh has nothing to disclose. |
| Arjun Peddireddy, BA |
Mr. Peddireddy has nothing to disclose. |
| Ilse Kulderij |
Ilse Kulderij has nothing to disclose. |
| Anne-Kathrin Kienzler |
Anne-Kathrin Kienzler has nothing to disclose. |
| Arshad Mujeebuddin, MBBS |
Dr. Mujeebuddin has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease. Dr. Mujeebuddin has stock in AstraZeneca. |
| Melissa Diaz, MD |
Dr. Diaz has nothing to disclose. |
| Arlette Aouad, MD |
Mr. Aouad has nothing to disclose. |
| David Bennett, MD, PhD |
Prof. Bennett has a non-compensated relationship as a Consultant with AditumBio that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with AstraZeneca that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Biogen that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Biointervene that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Combigene that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with LatigoBio that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with GSK that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Ionis that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Lexicon therapeutics that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Neuvati that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Novo Ventures 2023 that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consutlant with Olipass that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Orion that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Replay that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with SC Health Managers that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Third Rock ventures that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Vida Ventures that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a received research funding with Lily that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a received research funding with Astra Zeneca that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a received an industrial partnership grant from AZ & the BBSRC with Astra Zeneca that is relevant to AAN interests or activities. |
| Sophia Michael, PhD, MBChB; DPhil (Oxon) |
Dr. Michael has nothing to disclose. |
| Meng Zhao |
Dr. Zhao has nothing to disclose. |
| Laura Handal-Abularach, MD |
Dr. Handal-Abularach has nothing to disclose. |
| Karina Koh, MD |
Dr. Koh has nothing to disclose. |
| Yanis Saheb |
Mr. Saheb has nothing to disclose. |
| SUSAN K. FLAVIN |
Dr. FLAVIN has received personal compensation for serving as an employee of Horizon Therapeutics. Dr. FLAVIN has received personal compensation for serving as an employee of Amgen, Inc. Dr. FLAVIN has stock in Johnson and Johnson. Dr. FLAVIN has stock in Horizon Therapeutics. Dr. FLAVIN has stock in Amgen, Inc. Dr. FLAVIN has received intellectual property interests from a discovery or technology relating to health care. |
| Cinthia J. Ruhe |
Miss Ruhe has nothing to disclose. |
| Gianfranco Carbajal, MS |
Mr. Carbajal has nothing to disclose. |
| Didier L. Moreno Marquina, Medical student |
Mr. Moreno Marquina has nothing to disclose. |
| Leonardo A. Arquinigo, Jr., Medical student |
Mr. Arquinigo has nothing to disclose. |
| Simon J. Davis, PhD |
Prof. Davis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MiroBio Ltd. Prof. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sidley Austin LLP. Prof. Davis has received research support from Wellcome Trust. Prof. Davis has received research support from Medical Research Council. Prof. Davis has received intellectual property interests from a discovery or technology relating to health care. |
| Jonathan Abele |
The institution of Jonathan Abele has received research support from Canadian Neuroendocrine Tumor Society. |
| Parisa Aijaz |
No disclosure on file
|
| Imad Al-Dakkak |
Imad Al-Dakkak has received personal compensation for serving as an employee of AstraZeneca. Imad Al-Dakkak has stock in AstraZeneca. |
| Erica Andres |
Erica Andres has nothing to disclose. |
| Amelia Y. Aw |
No disclosure on file
|
| Jessica Becker |
No disclosure on file
|
| Kathleen Bradford |
Kathleen Bradford has nothing to disclose. |
| Supavit Chesdachai |
Supavit Chesdachai has nothing to disclose. |
| Vidya Chitikireddi |
Vidya Chitikireddi has nothing to disclose. |
| Panayotes Demakakos |
Panayotes Demakakos has nothing to disclose. |
| Lisa Dill |
Lisa Dill has nothing to disclose. |
| Anastasios Dimou |
Anastasios Dimou has nothing to disclose. |
| Wen Gao |
No disclosure on file
|
| Adrian Gardner |
Adrian Gardner has nothing to disclose. |
| Keisha Gibson |
No disclosure on file
|
| Elina Kadykova |
No disclosure on file
|
| Patricia Kelly |
No disclosure on file
|
| Laura Kersten |
Laura Kersten has nothing to disclose. |
| Jeroen Kerstens, MD |
Mr. Kerstens has received research support from European Joint Programme on Rare Diseases. The institution of Mr. Kerstens has received research support from Erasmus Trust Fund. |
| Chelsey Kret |
Chelsey Kret has nothing to disclose. |
| Nikolay Kurgaev |
No disclosure on file
|
| Cynthia Liu |
Cynthia Liu has nothing to disclose. |
| Melissa Mandarakas |
Melissa Mandarakas has nothing to disclose. |
| David Meyronet |
No disclosure on file
|
| Sammy Olijslagers |
Sammy Olijslagers has nothing to disclose. |
| Ray Owens |
Ray Owens has received intellectual property interests from a discovery or technology relating to health care. |
| Eleonora Sabatelli |
Eleonora Sabatelli has nothing to disclose. |
| Keia Sanderson |
No disclosure on file
|
| Akshatha Sudhir |
No disclosure on file
|
| Brigit Thomassen |
Brigit Thomassen has nothing to disclose. |
| Anke Tolido |
Anke Tolido has nothing to disclose. |
| Lismelia Vargas |
Lismelia Vargas has nothing to disclose. |
| Sharon Veenbergen |
Sharon Veenbergen has nothing to disclose. |
| Julia Verkoelen |
Julia Verkoelen has nothing to disclose. |
| Tanzeel Wani |
No disclosure on file
|
| Katherine Westreich |
No disclosure on file
|
| Neda Wick |
Neda Wick has nothing to disclose. |
| Feifei Yang |
Feifei Yang has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Feifei Yang has stock in Alexion Pharmaceuticals. |
| Hua Zhang |
No disclosure on file
|
| Jon Rosenberg, MD |
Dr. Rosenberg has nothing to disclose. |
| Melanie Delgado |
Melanie Delgado has nothing to disclose. |
| Unnah Leitner |
No disclosure on file
|
| Lisa Petersen |
No disclosure on file
|
| Gabrielle Pancio |
Gabrielle Pancio has nothing to disclose. |
| Timothy Erickson |
Timothy Erickson has received research support from Centers for Disease Control and Prevention. |
| Anvay Shah, MD |
No disclosure on file
|
| Vishrut Shah |
No disclosure on file
|
| Puja Punukollu |
No disclosure on file
|
| Sahithi Avva, MBBS |
Dr. Avva has nothing to disclose. |
| Josiane Stadler |
Ms. Stadler has nothing to disclose. |
| Mariama Boubacar Diallo |
Dr. Diallo has nothing to disclose. |
| Hunter Berry |
No disclosure on file
|
| Sanjay Rajan |
No disclosure on file
|
| Smriti Rajan |
Smriti Rajan has nothing to disclose. |
| Matthew Sagnelli |
No disclosure on file
|
| Ana Santos, MD |
Ms. Santos has nothing to disclose. |
| Anthony Hong, MD |
Dr. Hong has nothing to disclose. |
| Dominique Comeau |
Dominique Comeau has nothing to disclose. |
| Remi LeBlanc |
No disclosure on file
|
| Olivia Cull |
No disclosure on file
|
| Nathan Olson |
No disclosure on file
|
| Ysatis Ruiz |
No disclosure on file
|
| Pei Shang, MD, PhD |
Dr. Shang has nothing to disclose. |
| James Milburn |
No disclosure on file
|
| Ansam Hasan |
No disclosure on file
|
| Ye Gao |
No disclosure on file
|
| Yuqiao Liao |
No disclosure on file
|
| Anu Sehgal, MD |
Anu Sehgal has nothing to disclose. |
| Robert Morales |
No disclosure on file
|
| Silvia Narduzzi |
No disclosure on file
|
| Meheni Khellaf |
No disclosure on file
|
| Irene Gomez Oropeza |
Ms. Gomez Oropeza has nothing to disclose. |
| Sofia Zappacosta |
No disclosure on file
|
| Emma Lipshultz |
No disclosure on file
|
| Adam Handel |
The institution of Adam Handel has received research support from Medical Research Council (UK). The institution of Adam Handel has received research support from UCB-Pharma. The institution of Adam Handel has received research support from MyAware. |
| Yihan Zhang |
No disclosure on file
|
| Isabella Gomez Hjerthen |
No disclosure on file
|
| Richard J. Sliva, MD |
Richard Sliva has nothing to disclose. |
| Preston Seaberg |
No disclosure on file
|
| Colton Hoffer |
No disclosure on file
|
| Muhammad Javaid |
No disclosure on file
|
| Jordan Ciuro |
No disclosure on file
|
| Elena Schiopu |
No disclosure on file
|
| Abigail Donovan |
No disclosure on file
|
| Paul Gulotta |
No disclosure on file
|
| Yadi Li |
No disclosure on file
|
| Mariama Boubacar DIALLO, MD |
Dr. DIALLO has nothing to disclose. |
| Muzi Wen |
Muzi Wen has nothing to disclose. |
| Ruoyi Zheng |
Ruoyi Zheng has nothing to disclose. |
| Shannon Tung |
No disclosure on file
|
| Paloma Peter Travassos Zaidan |
No disclosure on file
|
| Qing Zhong |
No disclosure on file
|
| Mysha Sissine, MSPH |
No disclosure on file
|
| Sandra Orozco-Suarez, PhD |
Dr. Orozco- Suarez has nothing to disclose. |
| Akankshi Oberoi, MBBS |
Dr. Oberoi has nothing to disclose. |
| Ashley Foster |
No disclosure on file
|
| Madison Starcher, MD |
No disclosure on file
|
| Esther van den Berg, PhD |
Dr. van den Berg has nothing to disclose. |
| Matthew J. Schniederjan |
Mr. Schniederjan has received publishing royalties from a publication relating to health care. |
| Melissa Lee, NP |
Mrs. Lee has nothing to disclose. |
| Jessica Becker, MD |
An immediate family member of Dr. Becker has received personal compensation for serving as an employee of SmartLabs. An immediate family member of Dr. Becker has stock in Second Lab, LLC. The institution of Dr. Becker has received research support from American Academy of Child and Adolescent Psychiatry and Industry Sponsors. |
| Richard Sliva, MD |
No disclosure on file
|
| Nicole Baldwin, MD |
Dr. Baldwin has received personal compensation in the range of $500-$4,999 for serving as a volunteer international neurology instructor with CMDA, MAP International, and INMED (NGOs). |